RMTI
ROCKWELL MEDICAL, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$8.07
−0.25%Nov 3, 2026, 22:10 UTC
Rockwell Medical entered into a loan, security and guarantee agreement for $100 million in term loans, comprising two $50 million tranches, to finance the acquisition.
Nov 3, 2026, 11:01 UTC
VANTIVE announced a definitive agreement to divest most of its hemodialysis assets and associated operations to ROCKWELL MEDICAL, INC..
Source:Oct 15, 2026, 10:00 UTC
ROCKWELL MEDICAL, INC. announced that it will release its third-quarter 2026 results on November 12, 2026.
Source:Aug 13, 2026, 10:00 UTC
Rockwell Medical announced its second quarter 2026 results, reporting strong year-over-year growth, expanded gross margin, and positive operating cash flow.
Jun 29, 2026, 10:00 UTC
Rockwell Medical's board authorized a 1-for-10 reverse stock split, effective July 1, 2026.